Informatie:
Fout:
ID
29397
Beschrijving
Study part: Subset PK Sample Informed Consent Screening. A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus.
Trefwoorden
Versies (1)
- 21-03-18 21-03-18 -
Houder van rechten
Roche
Geüploaded op
21 maart 2018
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Subset PK Sample Informed Consent Screening Ranibizumab Macular Edema Diabetes Mellitus FVF4170g
Subset PK Sample Informed Consent Screening
- StudyEvent: ODM
Similar models
Subset PK Sample Informed Consent Screening
- StudyEvent: ODM
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
Subset PK Sample Informed Consent Screening
C0201734 (UMLS CUI-1)
C0370003 (UMLS CUI-2)
C0370003 (UMLS CUI-2)
Subject number
Item
Subject number:
text
C2348585 (UMLS CUI [1])
Subject initials
Item
Subject initials:
text
C1997894 (UMLS CUI [1,1])
C2986440 (UMLS CUI [1,2])
C2986440 (UMLS CUI [1,2])
Visit date
Item
Visit date:
date
C1320303 (UMLS CUI [1])
Study Subject Participation Status
Item
Not Applicable (Subject not participating)
boolean
C2348568 (UMLS CUI [1])
Informed Consent Date
Item
Date subject signed research sample informed consent:
date
C2985782 (UMLS CUI [1])